This is an Open Access article licensed under the terms of the Creative Commons AttributionNonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only. has wide range of biochemical and pharmacological effects, including antineoplastic effect, but the exact mechanisms remain unclear. The aim of the present study was to evaluate the potential chemo-sensitization effect of berberine in ovarian cancer cell line A2780. Methods:
Introduction
Ovarian cancer remains the most lethal form of all gynecological malignancies [1] . Approximately 23,000 women are diagnosed with ovarian cancer each year, and the 5-year cancer is often detected in an advanced stage. In this situation, the patients usually have to undergo surgery to remove the tumor and receive chemotherapy using anticancer drugs, such as cisplatin and its platinum derivatives. Most patients are responsive to chemotherapy target tissues, and acquire resistance to conventional chemotherapeutics [3] . Therefore, it is important to explore new types of drugs that reverse chemotherapy resistance and enhance sensitivity to platinum-based chemotherapy drugs.
Berberine, a clinically important natural isoquinoline alkaloid derived from Huang Lian and other medicinal herbs, has been reported to exhibit multiple pharmacological activities including anti-cancer effect [4] [12] . In most cases, berberine was found to inhibit cell cycle progression and to induce apoptosis. In addition, berberine may impair tumor growth on lung cancer cells by inducing autophagy [14] . A recent study showed that berberine could modulate the anticancer effects of doxorubicin in mutliple human cancer cells [15] . But the mechanisms of berberine enhance sensitivity to chemotherapy drugs remain unclear. a novel strategy for ovarian cancer therapy. The present study was therefore performed to test this hypothesis in ovarian cancer cell line A2780. Our study revealed that berberine enhances the antitumor effects of cisplatin in ovarian cancer cells through miR-93/PTEN/ AKT signaling pathway.
Materials and Methods

Cell lines and culture
The human ovarian cancer cell line A2780 was purchased from the Institute of Shanghai Cell Biology. The CDDP-resistant cell line A2780/DDP was induced using progressive concentration of CDDP as described previously [16] . A2780 and A2780/DDP cells were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum. All of the cell culture media contain 100 μg/ml streptomycin and 100 units/ml penicillin. Table 1 .
Annexin V and PI double staining for apoptosis analysis
number of apoptotic cells/the number of total cells in each group. Each measurement was repeated three times independently.
Luciferase reporter assay
To construct a luciferase reporter vector, the PTEN 3-UTR fragment containing putative binding activity in the corresponding well.
Western blot , phospho-AKT1, CA 
Results
Berberine inhibits the proliferation of ovarian cancer cells the parental A2780 cells. As previously reported for other types of cancer cells, berberine treatment alone had a growth-inhibitory effect on ovarian cancer cells in a dose-dependent effects on the growth of A2780 and A2780/DDP cells, while the anti-proliferative effect was observed at higher concentrations. To further probe the regulatory mechanisms of berberine, we conducted a cell-cycle assay. A higher proportion of A2780 cells treated with berberine 
PTEN is a direct target of miR-93 in ovarian cancer cells
To further clarify the molecular mechanisms of miR-93 in cisplatin sensitivity, we used a change of miR-93. Furthermore, RT-PCR and western blot analysis showed that the mRNA levels and protein levels of PTEN decreased after transfection of miR-93 mimics compared These data indicated that PTEN is directly and negatively regulated by miR-93. the expression of miR-93 in A2780 -ted with miR-93 mimics, and were subsequently treated with various doses of cisplatin. Cell viability was determined using a MTT assay. *P
PTEN/AKT is a key pathway in cisplatin resistance in ovarian cancer cells
To explore the relationship between PTEN and resistance-induced cytotoxicity, we transfected PTEN siRNA or a NC into A2780 cells, followed by treatment with various doses siRNA increased the ratio of the phosphorylated AKT/total AKT, and this could be partly were treated with PTEN siRNA had increased survival compared to NC group and this could that were treated with PTEN siRNA had a survival pattern that is similar to cells with miR-93 overexpression, suggesting that miR-93 confers resistance resistance via regulating PTEN/ AKT in the A2780 cells.
Discussion
pathway [20, 21] . Recently, more and more studies have found that miRNAs modulate drug resistance of cancer cells, at least in part, through this mechanism [22] . In our study, we regulating miR-93. resistance frequently develops in recurrent disease [23] . As such, understanding the signaling networks that regulate drug resistance is critical for successful treatment. A growing body of evidence indicates miRNAs play an important regulatory role in biological processes including proliferation, differentiation, apoptosis, metastasis, and drug resistance [24, 25] . Thus far, there are several published miRNAs that were reported to be associated with cisplantin resistance in varies tumors include miR-451, miR-21, miR-214, miR-23a and miR-141 [26-28] . MiR-93 is a typical member of miR-106b-25 clusters. Fu et al. reported that compared with cisplatin-sensitive parental cell lines [16] . In the present study, we found that miR-93 was upregulated in A2780/DDP cells compared to A2780 cells, indicating that miR-DDP cells to cisplatin via inhibiting miR-93 expression. MiR-93 may be a target of berberine.
Of miR-93 targets, we focused on the phosphatase and tensin homolog deleted on increased cell survival and had an overall effect that was similar to miR-93 overexpression. It has been well reported that constitutive activation of AKT contributes to chemoresistance in different types of tumors, including ovarian carcinoma [31] . Recent studies have demonstrated BIM as a key regulator participating in the AKT pathway in cisplatin-sensitive family member of PTEN regulator, blocks PTEN translation leading to activation of the AKT pathway and played an important role in regulating cisplatin chemosensitivity pathway in . As a result of the limitation of time and experimental conditions, only one cell line used in this 
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Berberine/miR-93 axis in other ovarian cancer cell lines in the later study.
In conclusion, our data indicated that berberine inhibited miR-93 expression and increased PTEN protein levels in the ovarian cancer A2780/DDP cells. Increased miR-93 expression plays important roles in the resistance to cisplatin in ovarian cancer cells. Meanwhile, PTEN/AKT pathway may mediate miR-93-induced chemoresistance to cisplatin in A2780 cells. The miR-93/PTEN/AKT axis provides a new avenue toward understanding the mechanism of drug resistance and may help us develop potential therapeutics against ovarian cancer.
